Appointment of COO

Summary by AI BETAClose X

4basebio PLC has appointed Scott Lorimer as Chief Operating Officer to support its accelerated growth strategy and transition from an R&D-driven to a commercial organization. Lorimer brings approximately 30 years of experience in bioprocess development and commercial manufacturing of biologics and cell and gene therapies, with a proven track record in scaling operations and obtaining regulatory approval for GMP manufacturing facilities. He will oversee the scaling of the company's synthetic DNA platform to meet demand in the cell and gene therapy, mRNA, and vaccine markets, working alongside the new CEO, Dr. Amy Walker, who was appointed in February 2026 to drive commercial expansion.

Disclaimer*

Companies

4basebio (4BB)
UK 100

Latest directors dealings